(Q43884128)

27 November 2017

0 references

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis (English)

1 reference

27 November 2017

0 references

1 reference

4

1 reference

27 November 2017

Magí Farré

1

1 reference

27 November 2017

Anna Mas

series ordinal

2

1 reference

27 November 2017

Marta Torrens

series ordinal

3

1 reference

27 November 2017

Jordi Camí

series ordinal

5

1 reference

27 November 2017

1 February 2002

1 reference

Drug and Alcohol Dependence

27 November 2017

1 reference

27 November 2017

65

1 reference

27 November 2017

3

1 reference

27 November 2017

283-290

1 reference

Deaths attributable to methadone vs buprenorphine in France

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Ineffective use of psychoactive drugs. Methadone treatment is no exception

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Variations in methadone treatment practices. Results from a national study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Meta-analysis: State-of-the-Science

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Methadone maintenance treatment in opiate dependence: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Contingency management in outpatient methadone treatment: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Methadyl acetate vs methadone. A double-blind study in heroin users

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Induction with levomethadyl acetate: safety and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Meta-analysis: formulating, evaluating, combining, and reporting

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

A 3-year progress report on the implementation of LAAM in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Six deaths linked to concomitant use of buprenorphine and benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Meta-analyses of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Assessment and management of opioid withdrawal symptoms in buprenorphine‐dependent subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Dose-response effects of methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Methadone dose and treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Effect of government recommendations on methadone prescribing in South East England: comparison of 1995 and 1997 surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Methadone and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

A multilevel model framework for meta-analysis of clinical trials with binary outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Methods of reporting statistical results from medical research studies

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

Role of maintenance treatment in opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900171-5

7 January 2021

10.1016/S0376-8716(01)00171-5

Identifiers

DOI

1 reference

27 November 2017

1 reference